SILICON LABORATORIES INC. SLAB

Latest FY: 2025 Technology Semiconductors
Market Price $218.45
Market Cap $7.20B
P/E Ratio N/A
Quick Peer Compare (Technology):
Revenue (FY 2025) ↑34.3% YoY
$784.76M
3-Yr CAGR: -8.5%
Net Income ↑66.0% YoY
-$64.91M
Net Margin: -8.3%
Free Cash Flow ↑356.4% YoY
$65.79M
FCF Yield: 0.91%
EPS (Diluted) ↑66.6% YoY
$-1.98
Basic: $-1.98
Return on Equity Efficiency
-5.9%
ROA: -5.1%

📊 Multi-Year Historical Performance & Trends

Financial Performance History Revenue, Net Income & Free Cash Flow
Margins Trend (%) Gross, Operating & Net Margins
Balance Sheet Strength Cash, Debt & Equity
Cash Flow Generation Operating Cash Flow vs CapEx vs FCF

📈 Year-over-Year (YoY) Growth History (SLAB)

All monetary values in millions ($M)
Fiscal Year Revenue Revenue YoY Gross Profit Net Income Net Inc YoY Diluted EPS EPS YoY Op. Cash Flow Free Cash Flow FCF YoY
FY 2016 $644.8M $368.7M $61.5M $1.45 $105.4M $94.5M
FY 2017 $768.9M +19.2% $454.2M $47.1M -23.4% $1.09 -24.8% $189.5M $177.3M +87.5%
FY 2018 $868.3M +12.9% $521.4M $83.6M +77.5% $1.90 +74.3% $173.5M $149.1M -15.9%
FY 2019 $837.6M -3.5% $280.2M $19.3M -77.0% $-2.37 -224.7% $166.5M $150.2M +0.8%
FY 2020 $510.9M -39.0% $294.8M $12.5M -35.0% $-2.64 -11.4% $135.7M $115.3M -23.3%
FY 2021 $886.7M +73.5% $425.4M $2,117.4M +16,797.3% $-1.35 +48.9% $135.7M $115.3M 0.0%
FY 2022 $1,024.1M +15.5% $642.6M $91.4M -95.7% $2.54 +288.1% $91.2M $64.7M -43.9%
FY 2023 $782.3M -23.6% $460.6M $-34.5M -137.8% $-1.09 -142.9% $-30.3M $-52.6M -181.4%
FY 2024 $584.4M -25.3% $312.2M $-191.0M -453.4% $-5.93 -444.0% $-13.9M $-25.7M +51.2%
FY 2025 $784.8M +34.3% $457.0M $-64.9M +66.0% $-1.98 +66.6% $95.7M $65.8M +356.4%
$

Valuation

Market Price $218.45
Market Cap $7.20B
Enterprise Value N/A
P/E Ratio N/A
P/B Ratio 6.58
FCF Yield 0.91%
Dividend Yield N/A
Shares Outstanding 32,981,800
%

Profitability & Margins

Gross Margin 58.23%
Operating Margin -8.99%
Net Margin -8.27%
Return on Equity (ROE) -5.93%
Return on Assets (ROA) -5.11%
Asset Turnover 0.62x
Revenue 3-Yr CAGR -8.49%
🛡️

Financial Health & Liquidity

Current Ratio 0.49
Cash Ratio 2.53
Debt / Equity N/A
Debt / Assets N/A
Cash & Equivalents $364.22M
Total Debt N/A
Book Value / Share $33.18
💧

Cash Flow Efficiency

Operating Cash Flow $95.71M
Capital Expenditures (CapEx) $29.92M
Free Cash Flow $65.79M
OCF / Revenue 12.20%
FCF / Revenue 8.38%
FCF 3-Yr CAGR 0.57%
🏷️

Per Share Metrics

EPS (Diluted) $-1.98
EPS (Basic) $-1.98
Dividends / Share N/A
Book Value / Share $33.18
EPS YoY Growth 66.61%
🏛️

Balance Sheet (FY 2025)

Total Assets $1.27B
Total Liabilities $174.90M
Stockholders' Equity $1.09B
Current Assets $70.32M
Current Liabilities $143.79M